DB
David W. Boyer (Chief Corp. Affairs Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Neurocrine Biosciences, Inc. (NBIX). The largest single filing was $609K of NBIX (3,888 sh × $156.64, as filed), executed May 26. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$739K
shares × price, as filed
Last traded
Sep 14
Filed Sep 15
Median ADV $194.2M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.0M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
NBIXRecent filings
NBIXSALE
Neurocrine Biosciences, Inc.
View filing →
$130K826 sh × $157.45
Exec Sep 14
Filed Sep 15 · 5:03 PM ET NBIXSALE Neurocrine Biosciences, Inc. View filing → $609K
3,888 sh × $156.64
Exec May 26
Filed May 28 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. View filing → $112K
955 sh × $116.79
Exec Feb 13 2025
Filed Feb 14 2025 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. View filing → $169K
1,104 sh × $152.94
Exec Jan 31 2025
Filed Feb 4 2025 · 5:30 PM ET